1. The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands. (2nd January 2018) Authors: van Hulst, Marinus; Stevanovic, Jelena; Jacobs, Maartje S.; Tieleman, Robert G.; Kappelhoff, Bregt; Postma, Maarten J. Journal: Journal of medical economics Issue: Volume 21:Number 1(2018) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗